Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and...
11 insider purchases on record · latest filing 2025-06-05.
Insiders have also filed 296 sale transactions at LUNG.